🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521329-34-00
Completed Phase I

A study understanding how much CDR132L enters the bloodstream after injection under the skin compared to injection into a vein in healthy participants

2025-521329-34-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Cardiovascular Diseases
Decision date
26/01/2026
Enrollment target
32
Sites
Germany

Condition studied

Healthy volunteers, treatment for heart failure

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521329-34-00 on CTIS ↗ ← All trials in the EU